Avenue Therapeutics, Inc.
June 21, 2017
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Mr. Jeffrey Gabor
| Via: | EDGAR Submission |
| Re: | Avenue Therapeutics, Inc. | |
| Acceleration Request re. Registration Statement, as amended, on Form S-1 | ||
| (File No. 333-217552) |
Ladies and Gentlemen:
Avenue Therapeutics, Inc. hereby requests that the request for acceleration of the effective date of the above-referenced Registration Statement so that it would be declared effective at 5:00 p.m., Eastern Time, on Thursday, June 15, 2017, be withdrawn.
Please contact Matthew W. Mamak of Alston & Bird LLP with any questions or comments at 212-210-1256.
| AVENUE THERAPEUTICS, INC. | ||
| By: | /s/ Lucy Lu | |
| Lucy Lu | ||
| Chief Executive Officer | ||
| cc: | Matthew W. Mamak, Esq. |
